Myriad to Acquire Psychiatry-Focused PGx Firm Assurex | GenomeWeb

NEW YORK (GenomeWeb) – Myriad Genetics announced today that it plans to acquire mental health-focused pharmacogenetics firm Assurex Health for $225 million in upfront payments.

The deal, which will grant Myriad entry into the neuroscience space, also includes the potential for $185 million in performance-based milestone payments, the company added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.